Evaluation of Treatment Underreporting Using SEER-Medicare Data

使用 SEER-Medicare 数据评估治疗漏报

• 批准号: 8565098
• 负责人: ANTOINETTE STROUP
• 金额: $ 8.88万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-30 至 2013-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8565098
• 关键词: Affect; Algorithms; Characteristics; Code; Data; Data Reporting; Data Set; Endometrial; Evaluation; Female breast; Hormones; Immunotherapy; Link; Malignant neoplasm of prostate; Measures; Medicare; Medicare claim; Modeling; Pattern; Process; Provider; Quality Control; Radiation; Registries; Reporting; Review Literature; Testing; Update; Work; base; cancer diagnosis; cancer site; chemotherapy; interest; oligodendroglioma; programs; tumor; working group

The primary objectives of this study are to (1) work closely with the SEER working groups and NCI to develop and implement algorithms that would be applied to SEER-Medicare data to identify oligodendrogliomas, female breast and endometrial, and prostate cancers diagnosed from 1992-2009 that received radiation, chemotherapy, hormone, and/or immunotherapy treatment; and, (2) define the process for incorporating additional information into the existing SEER treatment variables in SEER*DMS.

本研究的主要目的是（1）与SEER工作组和NCI密切合作，开发和实施将应用于SEER-Medicare数据的算法，以识别1992-2009年诊断的接受放疗、化疗、激素和/或免疫治疗的少突胶质细胞瘤、女性乳腺癌和子宫内膜癌以及前列腺癌;以及（2）定义将附加信息纳入SEER*DMS中现有SEER处理变量的过程。